These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Chymase-directed serine protease inhibitor that reacts with a single 30-kDa granzyme and blocks NK-mediated cytotoxicity. Woodard SL; Jackson DS; Abuelyaman AS; Powers JC; Winkler U; Hudig D J Immunol; 1994 Dec; 153(11):5016-25. PubMed ID: 7963562 [TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of lymphocyte chymase I, a granzyme implicated in perforin-mediated lysis. Woodard SL; Fraser SA; Winkler U; Jackson DS; Kam CM; Powers JC; Hudig D J Immunol; 1998 May; 160(10):4988-93. PubMed ID: 9590247 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and kinetic studies of diphenyl 1-(N-peptidylamino)alkanephosphonate esters and their biotinylated derivatives as inhibitors of serine proteases and probes for lymphocyte granzymes. Abuelyaman AS; Jackson DS; Hudig D; Woodard SL; Powers JC Arch Biochem Biophys; 1997 Aug; 344(2):271-80. PubMed ID: 9264539 [TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin. Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821 [TBL] [Abstract][Full Text] [Related]
8. Human granzyme B is essential for DNA fragmentation of susceptible target cells. Su B; Bochan MR; Hanna WL; Froelich CJ; Brahmi Z Eur J Immunol; 1994 Sep; 24(9):2073-80. PubMed ID: 8088328 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones. Anel A; Gamen S; Alava MA; Schmitt-Verhulst AM; Piñeiro A; Naval J J Immunol; 1997 Mar; 158(5):1999-2006. PubMed ID: 9036942 [TBL] [Abstract][Full Text] [Related]
10. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Odake S; Kam CM; Narasimhan L; Poe M; Blake JT; Krahenbuhl O; Tschopp J; Powers JC Biochemistry; 1991 Feb; 30(8):2217-27. PubMed ID: 1998680 [TBL] [Abstract][Full Text] [Related]
11. Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets. Bajpai A; Kwon BS; Brahmi Z Immunology; 1991 Oct; 74(2):258-63. PubMed ID: 1721042 [TBL] [Abstract][Full Text] [Related]
12. Characterization, application and potential uses of biotin-tagged inhibitors for lymphocyte serine proteases (granzymes). Winkler U; Allison NJ; Woodard SL; Gault RA; Ewoldt GR; Kam CM; Abuelyaman A; Powers JC; Hudig D Mol Immunol; 1996; 33(7-8):615-23. PubMed ID: 8760273 [TBL] [Abstract][Full Text] [Related]
14. [The serine proteases and their function in neuronal death processes]. Fuster Lluch O; Galindo MF; Ceña V; Jordán J Rev Neurol; 2004 Mar 1-15; 38(5):449-57. PubMed ID: 15029525 [TBL] [Abstract][Full Text] [Related]
15. Mechanism-based isocoumarin inhibitors for serine proteases: use of active site structure and substrate specificity in inhibitor design. Powers JC; Kam CM; Narasimhan L; Oleksyszyn J; Hernandez MA; Ueda T J Cell Biochem; 1989 Jan; 39(1):33-46. PubMed ID: 2654146 [TBL] [Abstract][Full Text] [Related]
16. Biotinylated isocoumarins, new inhibitors and reagents for detection, localization, and isolation of serine proteases. Kam CM; Abuelyaman AS; Li Z; Hudig D; Powers JC Bioconjug Chem; 1993; 4(6):560-7. PubMed ID: 8305526 [TBL] [Abstract][Full Text] [Related]